US government unveils finalised drug prices under Inflation Reduction Act
The new drug prices are expected to save taxpayers $6bn in 2026 and provide $1.5bn in savings for patients, said the Biden Administration.
16 August 2024
16 August 2024
The new drug prices are expected to save taxpayers $6bn in 2026 and provide $1.5bn in savings for patients, said the Biden Administration.
The FDA rejected the therapy after the AdComm raised efficacy and ethical concerns in Lykos’ trials.
Evotec’s CEO Christian Wojczewski had previously announced a strategic reset after shutting down its gene therapy business earlier this year.
Professor Michael Lewis, the NIHR director of innovation, highlights the importance of UK pharma collaboration.
Gilead Sciences’ Livdelzi (seladelpar) has received an accelerated approval from the US Food and Drug Administration (FDA) to treat primary biliary cholangitis (PBC).
Clinical trials for the two RNA interference (RNAi) programmes are slated to commence in early 2025.
The FDA set a Prescription Drug User Fee Act goal date of 17 February next year.
The application is supported via data from the Phase III ADRIATIC clinical trial in LS-SCLC patients.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.